Title |
Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells
|
---|---|
Published in |
Journal of Experimental & Clinical Cancer Research, February 2009
|
DOI | 10.1186/1756-9966-28-28 |
Pubmed ID | |
Authors |
Kyoung-Ok Hong, Ji-Hong Kim, Ji-Soo Hong, Hye-Jung Yoon, Jae-Il Lee, Sam-Pyo Hong, Seong-Doo Hong |
Abstract |
The Akt/PKB family of kinases is frequently activated in human cancers, including oral squamous cell carcinoma (OSCC). Akt-induced epithelial-to-mesenchymal transition (EMT) involves downregulation of E-cadherin, which appears to result from upregulation of the transcription repressor Snail. Recently, it was proposed that carcinoma cells, especially in metastatic sites, could acquire the mesenchymal-to-epithelial reverting transition (MErT) in order to adapt the microenvironments and re-expression of E-cadherin be a critical indicator of MErT. However, the precise mechanism and biologic or clinical importance of the MErT in cancers have been little known. This study aimed to investigate whether Akt inhibition would restore the expression of E-cadherin and beta-catenin, reduce that of Vimentin, and induce the MErT in OSCC cells with low or negative expression of E-cadherin. We also investigate whether inhibition of Akt activity would affect the E-cadherin repressors and signaling molecules like NF-kappaB, ERK, and p38. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 1% |
Portugal | 1 | 1% |
China | 1 | 1% |
Canada | 1 | 1% |
Unknown | 82 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 22 | 26% |
Researcher | 18 | 21% |
Student > Master | 12 | 14% |
Student > Bachelor | 7 | 8% |
Professor > Associate Professor | 6 | 7% |
Other | 10 | 12% |
Unknown | 11 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 34 | 40% |
Biochemistry, Genetics and Molecular Biology | 18 | 21% |
Medicine and Dentistry | 13 | 15% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
Chemistry | 2 | 2% |
Other | 3 | 3% |
Unknown | 14 | 16% |